158 filings
Page 5 of 8
CORRESP
khls8foe 20
14 Nov 16
Correspondence with SEC
12:00am
UPLOAD
xa03lyg j8ss7azr46i
14 Nov 16
Letter from SEC
12:00am
8-K
sycmk8
9 Nov 16
Loxo Oncology Appoints Steve D. Harr, M.D., CFO of Juno Therapeutics, to Board of Directors
12:00am
8-K
c1jaczbulypnf70b3c0
2 Nov 16
Loxo Oncology Announces Third Quarter 2016 Financial Results
12:00am
8-K
14bi8hya
3 Aug 16
Results of Operations and Financial Condition
12:00am
8-K
i0z2aw3n562qz9
13 Jun 16
Departure of Directors or Certain Officers
12:00am
8-K
k29txsgqab
12 May 16
Loxo Oncology Prices Follow-On Offering of Common Stock
12:00am
424B5
3epvdlhx o5fx
12 May 16
Prospectus supplement for primary offering
12:00am
424B5
keragjpyq l4v18x
11 May 16
Prospectus supplement for primary offering
12:00am
8-K
844e2w557
4 May 16
Loxo Oncology Announces First Quarter 2016 Financial Results
12:00am
CT ORDER
8n440jtf8jj1pbujd
27 Apr 16
Confidential treatment order
12:00am
8-K
4ywese8w6no0
18 Apr 16
Loxo Oncology TRK Inhibitor LOXO-101 Shows Durable Anti-Tumor Activity Across TRK Fusion Cancers in AACR Phase 1 Update
12:00am
DEFA14A
hyyjqa
18 Apr 16
Additional proxy soliciting materials
12:00am
S-8
gn2n61kh6
15 Mar 16
Registration of securities for employees
12:00am
8-K
9xq89vl0eoq7wk8sur3o
15 Mar 16
Results of Operations and Financial Condition
12:00am